You are here: Industry Insights > Jubilant

News List

Jubilant HollisterStier partners with Ocugen to make Covaxin for US, Canadian markets expresspharma
June 17, 2021
Jubilant HollisterStier has manufacturing units in Spokane (US) and Montreal (Canada).
Ocugen and Jubilant Enter COVID-19 Vaccine Partnership contractpharma
June 16, 2021
Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.
Jubilant HollisterStier Expands Sterile Injectable Mfg. Capacity contractpharma
June 07, 2021
Jubilant HollisterStier is investing $92 million to expand sterile injectable manufacturing capacity at its site in Spokane, WA. The expansion includes the set up of a high-speed, 400 vials a minute, injectable fill line with isolator technology ...
HP India, Jubilant Bhartia Foundation introduce virtual helpdesk for Co-WIN registrations expresspharma
June 01, 2021
The virtual helpdesk will provide assistance initially in Hindi, English, Telugu, Tamil and Kannada and will add more regional languages soon.
Lupin, Sun Pharma, Jubilant Cadista recall generic medicines in US expresspharma
April 26, 2021
Lupin is recalling 17,814 bottles of Cefprozil, Sun Pharma is recalling 13,834 bottles of Riomet and Jubilant Cadista Pharmaceuticals is recalling 12,192 bottles of Itraconazole capsules.
Jubilant Pharma subsidiary announces development of novel oral formulation of Remdesivir expresspharma
April 20, 2021
Jubilant Pharma, a subsidiary of Jubilant Pharmova, announces successful completion of safety and pharmacokinetic/absorption studies in animals and healthy human volunteers in India using a novel oral formulation of remdesivir against the commercially ...
Jubilant, Novavax Enter COVID-19 Vaccine Partnership contractpharma
March 30, 2021
Jubilant to provide fill-finish manufacturing services for the production of COVID-19 vaccine candidate NVX-CoV2373.
Sun Pharma, Dr Reddy’s, Aurobindo, Jubilant recall products in US expresspharma
March 15, 2021
The Indian firms have initiated recall of these products for various reasons including failed impurities/degradation specifications, failed dissolution specifications, presence of foreign tablets, illegible label etc.
Jubilant Therapeutics Appoints Chief Scientific Officer contractpharma
March 10, 2021
Luca Rastelli brings more than 20 years of oncology drug discovery and development experience.
Jubilant HollisterStier, Eli Lilly Enter COVID-19 Treatment Collaboration contractpharma
March 10, 2021
The CMO signs manufacturing agreement with Lilly for COVID-19 therapeutic Bamlanivimab.

Previous page 1 2 Next page